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ABSTRACT: Disturbances in the serotonin (5-HT) system is the neu- 
robiological abnormality most consistently associated with suicide. 
Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis is also 
described in suicide victims. The HPA axis is the classical neuroen- 
docrine system that responds to stress and whose final product, corti- 
costeroids, targets components of the limbic system, particularly the 
hippocampus. We will review results from animal studies that point to 
the possibility that many of the 5-HT receptor changes observed in sui- 
cide brains may be a result of, or may be worsened by, the HPA over- 
activity that may be present in some suicide victims. The results of 
these studies can be summarized as follows: (1) chronic unpredictable 
stress produces high corticosteroid levels in rats; (2) chronic stress also 
results in changes in specific 5-HT receptors (increases in cortical 5- 
HTZA and decreases in hipocampal 5-HTlA and 5-HTlB); (3) chronic 
antidepressant administration prevents many of the 5-HT receptor 
changes observed after stress; and (4) chronic antidepressant adminis- 
tration reverses the overactivity of the HPA axis. If indeed 5-HT recep- 
tors have a partial role in controlling affective states, then their 
modulation by corticosteroids provides a potential mechanism by 
which these hormones may regulate mood. These data may also pro- 
vide a biological understanding of how stressful events may increase 
the risk for suicide in vulnerable individuals and may help us eluci- 
date the neurobiological underpinnings of treatment resistance. 
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INTRODUCTION 
Research studies in suicide attempters and suicide victims (two over- 
lapping but not identical populations) have implicated disturbances in the 
serotonin (5-HT) system as the neurobiological ”alteration” most consis- 
tently associated with suicide.’,’ As we will see below, several studies have 
also shown that dysregulation of the hypothalamic-pituitary-adrenal 
(HPA) axis can be found in suicide victims.s5 Although each of these sys- 
tems have been studied independently, their interaction in the brain, as it 
relates to the pathophysiology of suicide, has received relatively little 
attention. 
That disturbances in these two systems may share a common patho- 
physiological mechanism is not surprising, inasmuch as we know from 
animal studies that they interact extensively and that they are related in a 
variety of ways: The hippocampus, in particular, is an anatomical region 
in which components of the HPA and the 5-HT systems have a rich rep- 
resentation. This region is part of the limbic system, an area implicated in 
the regulation of several vegetative functions (arousal, sleep, appetite, and 
hedonic capacity) as well as in the control of cognitive function and of 
mood. Therefore, the hippocampus provides an ideal anatomical sub- 
strate to study the HPA axis, the serotonin system, and their potential role 
in suicide. 
It is clear that neurobiological abnormalities can be found in suicide 
victims, irrespective of diagnosis. However, not all suicides have a com- 
mon underlying psychiatric condition. An important question is whether 
the biological abnormalities that have been found in suicide victims are 
characteristic of a subpopulation or if there is a neurobiological precursor 
common to all suicides. For example, although disturbances in the 5-HT 
and HPA systems have been identified in suicide victims, they have also 
been implicated in affective disorders.’ This is particularly relevant, 
because, depending on the population, 40 to 60% of suicide victims have 
a history of affective Given this neurobiological link, an under- 
standing of the relationship between these two circuits can give us clues 
to the pathophysiology of both suicide and affective illness. 
STRESS AND THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS 
The HPA is the classic neuroendocrine system that responds to stress. 
Perception of stress by an organism results in a series of events whose final 
result is the secretion of glucocorticoids (cortisol in humans, corticosterone 
in rats) from the adrenal cortex.’O Activation and termination of the adreno- 
cortical stress response is critical for adaptation and survival. Inhibition of 
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stress responsiveness is partly achieved by the binding of circulating glu- 
cocorticoids to specific cytoplasmic receptors in the hypothalamus, where 
they inhibit corticotropin (CRH) and consequently pituitary adrenocorti- 
cotropin (ACTH) secretion. Additional modulation of the system is appar- 
ently achieved in limbic structures, specially the hippocampus, a structure 
that is linked to the hypothalamus through neuronal connections that con- 
verge on the paraventricular nucleus of the hypothalamus (PVN), where 
the stress responsive CRH and vasopressin (AVP) neurons reside.'O There 
are several lines of evidence that highhght the importance of the hip- 
pocampus for HPA feedback mechanisms. For example, hippocampal 
lesions in the adult rat result in increased circulating corticosterone, and 
increased CRH/AVP mRNA, suggesting a lost of a site critical to glucocor- 
ticoid-negative HPA feedback on basal expression of these secreta- 
gogues."J2 Further study of corticoid receptor molecules within this 
structure have provided evidence of their relevance to HPA feedback mech- 
anisms. It is also well established that the hippocampus is a central compo- 
nent of limbic circuitry and is fundamental in controlling aspects of 
cognitive and behavioral functions. 
Chronic stress can lead to specific alterations and changes in the activ- 
ity of the HPA axis. For example, in rats, chronic foot shock leads to an 
aberrant pattern of pituitary responsiveness to glucocorticoids and an  
impairment in feedback mechanisms.6J0This impaired feedback following 
chronic stress is associated with a decrease in glucocorticoid receptor 
(GR) gene expression in the hippocampus.13 Interestingly, some of the 
HPA changes seen after chronic stress in rodents can be prevented by the 
administration of antidepressant rnedicati~ns,'~ suggesting that correction 
of the HPA axis disturbances is associated with the therapeutic action of 
these compounds. 
The feedback abnormalities in chronically stressed animals resemble 
those seen in patients with depressive illnes~.'~, '~ This HPA dysregulation 
in depression is manifested by cortisol hypersecretion, failure to suppress 
cortisol secretion after dexamethasone administration and blunted 
response to CRH adrnini~tration,'~-~~ This last observation has been inter- 
preted as evidence for increased CRH drive, inasmuch as chronic CRH 
administration is known to cause down-regulation of pituitary CRH 
receptors.20 
STRESS, DEPRESSION, AND SUICIDE 
The relationship between stress and suicide is complex. It is impor- 
tant to distinguish between the psychological aspects of stress (with 
issues such as predictability, control, and coping) and the biological 
aspects of stress, which include activation of specific neuroendocrine cir- 
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cuits, such as the HPA axis. Although it is clear that the stress-related 
brain circuits (in particular the HPA) play a key role in stress respon- 
siveness, the sites critical for stress perception are not as clear. The exact 
relationship between the psychological aspects of stress, the biological 
aspects of stress, and suicide is unknown. However, we do know the fol- 
lowing: (1) Several clinical and epidemiological studies in suicide victims 
have identified psychosocial stressors (e.g., unemployment, a recent 
stressful life event) as important risk factors in suicide.2’-24 These factors 
have been identified both in suicide attempters and completers as a 
group, although clearly this does not imply that psychosocial stress is a 
key variable in all suicides. (2) As we have mentioned above, subjects 
with affective illness are a significant subpopulation in suicide vic- 
t i m ~ . ~ , ~ , * ~  Stressful life events have also been identified as important risk 
factors prior to the onset of depression.26 (3 )  Depressed patients have evi- 
dence of dysregulated stress systems at the biological level. Therefore, it 
is possible that evidence of HPA overactivity may be found in at least the 
subpopulation of suicide victims with a history of mood disorders, or in 
those who may have suffered from more severe psychological (and/or 
biological) stressors. 
Clinical neuroendocrinological studies have indeed found evidence of 
HPA overactivity both in completed suicides and in suicide attempters. 
For example, Norman27 found that depressed patients who had under- 
gone a dexamethasone suppression test (DST) and later committed sui- 
cide had significantly higher postdexamethasone levels than other 
(nonsuicidal) depressed patients. Ln another study, Roy2R found that vio- 
lent suicide attempters had higher cortisol levels than those who made 
nonviolent suicide attempts. Postmortem studies have also found evi- 
dence of chronic HPA activation in suicide victims, such as adrenal hyper- 
p la~ia , ‘ ,~~  increased CRH content in the cerebrospinal fluid,5 and 
downregulation of CRH receptors in the frontal cortex.70 We have found 
increases in POMC (the precursor molecule for ACTH) mRNA and pep- 
tide content in the pituitaries of suicide victims,’ which is an indication of 
chronic activation of the HPA axis. It is not clear if these postmortem 
changes are due to an underlying mood disorder in a subset of this pop- 
ulation, to the stress surrounding the suicidal act itself, or to a neurobio- 
logical abnormality common to all suicides irrespective of diagnosis. 
Nevertheless, the presence of a chronically hyperactive HPA axis has 
important biological consequences to the organism. In this paper, we 
review animal studies that indicate that the final products of the HPA axis 
can exert an important modulatory influence in some components of the 
serotonin system. These data strongly suggest that HPA overactivity is 
not merely an epiphenomenon of the suicidal state, but that it may be 
responsible for (or worsen) some of the 5-HT abnormalities found in sui- 
cide. This HPA dysregulation, therefore, is an important contributor to 
some pathophysiological disturbances that may lead to suicidal behavior. 
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SEROTONIN 1A RECEPTORS AND THE HPA AXIS 
Animal studies have shown that corticosteroids can alter several ele- 
ments of serotonergic neurotransmission. Removal of circulating corticos- 
teroids by adrenalectomy (ADX) results in anatomically specific decreases 
in indices of serotonin metabolism, whereas stressful procedures, which 
raise corticosteroid levels, produce corresponding increases in serotonin 
t ~ r n o v e r . ~ ' ~ ~  Activity of tryptophan hydroxylase, the rate-limiting sero- 
tonin biosynthetic enzyme, appears to be sensitive to circulating corticos- 
teroid 1e~el.s.~~ However, corticosteroids may also act to directly modulate 
serotonergic neurotransmission by regulating 5-HT receptors. 
Autoradiographic studies4 first identified increased 5-HT1 receptor bind- 
ing in the rat hippocampal formation one week after bilateral ADX. 
Subsequent investigations have confirmed the sensitivity of 5-HT1 recep- 
tors to circulating corticosteroid levels35 and indicate that specific hip- 
pocampal subfields are exquisitely sensitive to adrenal steroids. More 
recent electrophysiological studies have shown a suppression of 5-HT- 
induced hyperpolarizations within CA1 pyramidal cells after brief appli- 
cation of steriods,% establishing a functional coupling for steroid-sero- 
tonin receptor interactions within the hippocampus. 
The signal transduction mechanism for corticosteroids involves the 
translocation of hormonally bound cytosolic receptors to the cell nucleus, 
where association with specific genomic sites induces alterations in tran- 
scriptional efficiencies for particular genes.37 Pharmacological studies 
have defined at least two subtypes of corticosteroid receptors that differ 
in their affinity for cortic~sterone;~~ the mineralocorticoid receptor (MR), 
which resembles the peripheral kidney MR receptor and binds corticos- 
terone with high affinity; and the GR, which exhibits a 3 to 5-fold lower 
affinity for the endogenous ligand. Both autoradiographic and immuno- 
histochemical s t u d i e ~ ~ ~ ~ "  indicate that the hippocampus contains particu- 
larly high concentrations of both MR and GR compared to other brain 
regions. In situ hybridization studies confirm the intrahippocampal syn- 
thesis of these sites and reveal a heterogeneous distribution of both h4R 
and GR mRNAs across hippocampal sub field^.^' It, therefore, seems likely 
that the high concentration of corticosteroid receptors within the hip- 
pocampus underlies the sensitivity of 5-HT receptors to corticosteroid 
regulation in this region. 
The ascending serotonergic innervation of hippocampal neurons aris- 
ing in midbrain raphe nuclei provides one means by which the seroton- 
ergic system may act to regulate limbic function. Thus, the hippocampus 
represents a key anatomical structure involved in the central control of 
HPA axis functionlo and limbic CircuitryF As such, this area provides a 
unique anatomical environment in which to study the molecular interplay 
between serotonergic systems and corticosteroids. 
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The 5-HT1A receptor has been identified both as an inhibitory somato- 
dendritic receptor in raphe serotonergic cells and a post-synaptic receptor 
in selective serotonergic terminal fields.47 Its abundance in the limbic sys- 
tem, as well as evidence from animal and clinical studies, strongly sug- 
gests that the 5-HT1A receptor plays an important role in the 
pathophysiology of mood disorders. For example, a number of antide- 
pressant drugs, monoamine oxidase inhibitors, and tricyclics have been 
found to regulate hippocampal 5-HT1 A receptor number and responsive- 
ness,wh suggesting that this receptor subtype may be important in relation 
to the therapeutic actions of these compounds. In clinical studies, 5-HT1A 
partial agonists have been shown to be effective in the treatment of anxi- 
ety disorders,4' and major depression,M including the melancholic sub- 
type.49 Interestingly, the 5-HT1A agonist, buspirone, has been reported to 
augment the antidepressant response in patients who are antidepressant 
nonresponders.xl 
Although original ADX studies did not differentiate between 5-HT1 
receptor subtypes, autoradiographic data using subtype-specific ligands5' 
and in situ hybridization hist~chemistry~? indicated that the predominant 
postsynaptic hippocampal 5-HT1 receptor is of the 5-HT1A type, sug- 
gesting that 5-HTIA receptors may be regulated by adrenal steroids. 
Reported alterations in 5-HT1A receptor binding in response to ADX5' is 
certainly supportive of such a conclusion. This evidence suggests that the 
mechanisms underlying corticosteroid regulation of 5-HT1A receptors 
may contribute to steroid-mediated modulation of mood and, as such, 
may represent an important linkage both in the pathophysiology of sui- 
cide and in psychotherapeutic drug action. 
Our laboratory underwent a series of experiments designed to inves- 
tigate regulation of the 5-HT1A receptor in response to alterations in cir- 
culating corticosteroids.6, 54-56 Studies were designed to further our 
understanding of the mechanisms involved in corticosteroid-mediated 
modulation of the 5-HT1A receptor at the molecular and subanatomical 
level under conditions related to physiological and pathophysiological 
levels of steroids. As corticosteroids act predominantly at the level of neu- 
ronal gene expression, we employed in situ hybridization techniques in 
combination with receptor autoradiography to allow simultaneous visu- 
alization and quantification of both receptor gene expression and recep- 
tor dynamics in discrete anatomical subfields. More specifically we asked 
(1.) How do steroids regulate 5-HT1A receptors? Is there any evidence for 
anatomical or receptor specificity? What are the roles of MR and GR in 
mediating hippocampal 5-HT1A receptor regulation? How do hippocam- 
pal 5-HT1A receptors react to chronic stress? and Can antidepressant 
drug treatment alter 5-HT1A receptor binding and gene expression under 
conditions of chronic stress? 
We found that removal of circulating steroids by adrenalectomy 
resulted in a significant increase in 5-HT1A receptor binding and mRNA 
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in rat hippo~ampus.~>’ This increase was prevented if a low dose of cor- 
ticosterone was administered after adrenalectomy. The dose of corticos- 
terone used in this study is probably occupying MR selectively. 
Dexamethasone replacement after adrenalectomy was only partially 
effective in reversing the adrenalectomy-induced upregulation of 5-HTl A 
. Dexamethasone is primarily a GR agonist. These studies indicated that 
5-HT1A hippocampal receptors are under tonic inhibition by corticos- 
teroids, and this effect is predominantly mediated by MR. The role of MR 
in modulating hippocampal 5-HT1A under basal conditions has been 
confirmed by other laboratories58s9 using specific pharmacological agents. 
This regulation appears to be relatively site specific, inasmuch as 5-HT1A 
mRNA and binding in the dorsal raphe was not altered by removal of cir- 
culating steroid~.~’ There is also some receptor specificity, because 
dopamine D1 receptors and 5-HT2C receptors were not affe~ted.~’ 
We also examined the effect of persistent HPA activation on hip- 
pocampal5-HT1A receptors by using a chronic unpredictable stress par- 
adigm.w2 This paradigm causes persistent elevation of circulating 
corticosteroids and is therefore probably occupying both MR and GR 
simultaneously. After two weeks of chronic stress, 5-HT1A receptor 
mRNA levels and 5-HT1A binding densities were significantly reduced 
in the hippocampus, relative to control animals.5556 If imipramine is 
administered concomitantly to the chronically stressed animals, it pre- 
vents both the downregulation of hippocampal 5-HT1A receptors and 
the stress-induced increase in plasma corticosteroids. The mechanism by 
which chronic imipramine administration prevented 5-HTl A downreg- 
ulation is not clear, but its ability to attenuate the elevations of corticos- 
terone after chronic stress suggests that the beneficial effect of 
antidepressants on 5-HT1A receptors may be mediated, at least in part, 
by reducing HPA hyperactivity.63 Further evidence for this is provided by 
the observation that, when imipramine is unable to decrease corticos- 
terone levels, it is also unable to prevent 5-HT1A downregulation after 
chronic 
The direction of the effect of chronic stress on 5-HTlA receptors is in 
agreement with what would be expected based on the adrenalectomy 
studies (ie.,  upregulation in the absence of corticosteroids, downregula- 
tion with excess of corticosteroids). However, these results are merely cor- 
relative, because stress is a very complex biological response and, in 
addition to corticosteroid secretion, many other events are occurring, 
which could potentially be affecting 5-HT1A receptor levels. 
In order to elucidate whether the 5-HT1A downregulation observed in 
this paradigm is a consequence of the increase in plasma corticosterone, 
or if it is mediated by a central mechanism ( i e . ,  brain circuits activated 
during stress), we investigated the effect of chronic unpredictable stress in 
adrenalectomized (ADX) rats with and without corticosterone replace- 
ment (c~rt-replaced).~~ This was done in orther to prevent the persistent 
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rise of plasma corticosterone during prolonged stress. Six groups of ani- 
mals were studied: (1.) sham-operated animals that were not stressed 
(controls), (2.) sham animals that were stressed, (3.) ADX animals, non- 
stressed, (4.) ADX, stressed, (5.) cort-replaced, nonstressed, and (6.) cort- 
replaced, stressed. Chronic unpredictable stress was administered for 14 
days. All animals were sacrificed 24 hours after the last stress session. 
Corticosterone was measured by radioimmunoassay. Hippocampal 
5-HTlA mRNA was measured by in situ hybridization. The results of this 
experiment are seen in FIGURE 1. We found that plasma corticosterone sig- 
nificantly increased in the sham-stressed animals compared to the other 
groups. In these sham-stressed animals, chronic stress caused a consistent 
decrease in 5-HTlA mRNA in all hippocampal subfields, although the 
decrease achieved statistical significance only in CA3 and the dentate 
gyrus (DG) (p < 0.05 by ANOVA). No 5-HT1A mRNA downregulation 
was observed in the ADX stress or cortisone -replaced stress groups com- 
pared to controls. Therefore, elimination of the corticosterone rise after 
stress prevented the decrease in hippocampal 5-HTl A. These results indi- 
cate that the 5-HT1A down-regulation observed after chronic stress is 
mostly mediated by increases in plasma corticosterone levels. 
Interestingly, chronically stressed rats that were ADX and received corti- 
costerone replacement also had lower 5-HT1A levels than controls. 
Whether this represents a chance event or the fact that there is indeed a 
small effect of stress independent of corticosteroid levels, remains to be 
investigated. 
The results of these experiments suggest that corticosteroids, by inter- 
acting with the 5-HT1A receptor, may play an important role in the rela- 
tionship among stress,h5 mood changes,6" and perhaps suicide. Because 
hypersecretion of endogenous corticosteroids in animal models can 
decrease 5-HT1A receptor expression, it may be possible that the hyper- 
cortisolemia found in depressed patients can exacerbate disturbances in 
affective states associated with 5-HT1A receptor function. If t h s  is the 
case, then antidepressant medications, in addition to directly correcting a 
central monoaminergic disturbance, may act to improve serotonergic 
function indirectly by decreasing cortisol hypersecretion. We have found 
some evidence that these mechanisms may be operating in the human 
brain. In a small number of suicide victims with a history of depression, 
we found decreases in 5-HT1A mRNA levels in several hippocampal sub- 
fields, compared to nonsuicide The decreases in 5-HT1A gene 
expression ranged from 30% to 45%, depending on the hippocampal sub- 
field, with the greatest decrease found in CA3. There was also a reduction 
in MR mRNA levels in the same hippocampal regions. This is consistent 
with a history of exposure to high corticosteroid levels, and therefore con- 
sistent with the animal data of corticosteroid-mediated 5-HT1A mRNA 
downregulation. Serotonin 1 A  receptor binding has also been found to be 
decreased in the pars opercularis and temporal lobe of elderly depressive 
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FIGURE 1. Effect of chronic unpredictable stress, adrenalectomy (ADX), and cor- 
ticosterone (B) replacement on plasma corticosterone (A) and 5-HT,, mRNA lev- 
els (B). Intact (sham) animals that underwent 14 days of chronic unpredictable 
stress showed a decrease in 5-HT,, mRNA compared to the non-stressed group. 
ADX with and without B replacement abolished the differences between the 
stressed and nonstressed animals. ‘Significantly different from sham by ANOVA, 
p 5 0.05. , sham; I, sham stress; I, ADX; Q, ADX stress; I, ADX + B; 
0 ,  ADX + B + stress. 
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patients.~ This last observation is of interest to the potential relationship 
between hypercortisolemia and 5-HT1A receptors, inasmuch as aging is 
associated with worse impairment of HPA axis function.h7 
Because ADX and steroid administration are known to cause acute 
effects on 5-HT content and release, it is possible that corticosteroids are 
modulating 5-HT1A receptor levels secondarily, through 5-HT synaptic 
changes. However, hippocampal 5-HT1 A receptors, as assessed by ligand 
binding, have proven to be remarkably resistant to homologous regulation, 
even after complete loss of serotonin stimulation as a result of a neurotoxic 
lesion.ha,h’ Similarly, significant depletion of hippocampal serotonin 
appears to produce only relatively small, or no, changes in 5-HTlA recep- 
tor mRNA within hippocampal sub field^.'^) It is, therefore, most likely that 
changes in both 5-HT1A mRNA expression and 5-HT1A binding observed 
in response to stress do not result from stress-induced changes in seroton- 
ergic activity but rather reflect a direct effect on hippocampal neurons. 
Due to the abundance of MR and GR receptors in this brain area, cor- 
ticosteroid-induced downregulation of 5-HTl A is likely an effect specific 
to the hippocampal formation. Some postmortem studies have reported 
an increase in 5-HT1A binding in the prefrontal cortex of suicide vic- 
tim.?1.72 Although this is in apparent contradiction with the findings of 
decreased 5-HTlA in the hippocampus, the results of these studies are not 
necessarily inconsistent. Regulation of 5-HT1A receptors may be different 
in different brain regions. For example, hippocampal 5-HTl A receptors, 
due to their colocalization with MR and GR,3s,-7h,52 may be more sensitive 
to circulating steroids, whereas receptors in the prefrontal cortex may be 
less responsive to steroids and more responsive to changes in local 5-HT 
levels. As we will see below, these 5-HT1A changes in the prefrontal cor- 
tex are in the same direction as those reported for the 5-HT2A receptor in 
the same anatomical region.7’ 
SEROTONIN 1B RECEPTORS, SEROTONIN 2A RECEPTORS, 
CORTICOSTEROIDS, AND STRESS 
The 5-HT1A receptor is not the only serotonin receptor whose func- 
tion may be relevant to the pathophysiology of suicide. Recent animal 
studies have implicated the 5-HT1 B receptor in impulsive and aggressive 
beha~ior .~~, ’~  In a resident-aggression test, mutant mice lacking the 5-HT1B 
receptor show a significant increase in impulsive attacks, compared to 
wild-type m i ~ e . ~ ~ , ’ ~  In addition, some 5-HT1B agonists, called ”serenics,” 
have been shown to decrease aggression in several behavioral para- 
digm~.’~ The 5-HT1B receptor is located both presynaptically (where it is 
believed to control serotonin release) and po~tsynaptically.~~ The antiag- 
gressive effects of 5-HT1B are believed to be mediated by the postsynap- 
tic inasmuch as lesioning the central serotonergic system does 
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not alter the antiaggressive properties of serenics. These animal studies 
have important implications for the neurobiology of suicide, inasmuch as 
impulsive behavior in humans (including violent suicide) has been asso- 
ciated with a decrease in central serotonergic activity.80 Ramboz et al.” 
have speculated that low serotonergic activity could result in a decreased 
activation of the postsynaptic 5-HT1B receptor, which may result in 
aggressive and/or impulsive behavior. 
There is a paucity of studies investigating whether stress and/or corti- 
costeroids can modulate 5-HT1B receptors. Mendelson and McEwenB1 
measured 5-HT1B receptor binding in the rat hippocampus after ADX and 
corticosterone administration. They found that ADX increased 5-HTlB 
binding in the DG and that high doses of corticosterone reduced the bind- 
ing below sham levels. Corticosterone also reduced 5-HT1B binding in 
area 2 of the cortex.81 Because receptor binding studies using 
125iodocyanopindolol will visualize both the presynaptic and postsynaptic 
5-HT1B receptor, it is not known which hippocampal cells and which 
receptors (pre- vs. postsynaptic) are regulated by corticosterone. 
We therefore used in situ hybridization to study the regulation of the 
postsynaptic 5-HT1B receptor in the hippocampus, using the same ADX- 
cort-replaced animals in which 5-HT1A regulation was studied (FIG. 2). 
5-HT1B mRNA is found in the cell bodies of the pyramidal neurons of the 
FIGURE 2. Two weeks of chronic unpredictable stress resulted in a small, but sig- 
nificant, decrease in 5-HT1B mRNA in CAI compared to controls. t Significantly 
different from sham animals by ANOVA, p 2 0.05. 
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CA1 hippocampal subfield, and these neurons project axons to the dorsal 
subicu1um.R2 Two weeks of chronic unpredictable stress resulted in a small, 
but significant decrease in 5-HT1B mRNA in CA1 compared to controls 
(Fig. 2). This decrease was prevented if rats were ADX prior to undergoing 
the stress schedule, indicating that the decrease in postsynaptic 5-HT1B 
after stress is mediated, for the most part, by circulating corticosteroids. To 
the extent that postsynaptic 5-HT1B receptors are involved in modulating 
impulsive and/or aggressive behavior, these results would suggest that 
stress, by downregulating 5-HT1B receptors, may be capable of influenc- 
ing, triggering, or worsening impulsive behavior. 
Another serotonin receptor closely associated with the neurobiology 
of suicide is the 5-HT2A receptor. An increase in 5-HT2A receptor num- 
ber (a postsynaptic receptor) in the prefrontal cortex of suicide victims has 
been reported by several investigators.R,Ws Some studies have not repli- 
cated these findings, but factors such as prior medication use may account 
for some of the discrepancies. Interestingly, chronic antidepressant treat- 
ment causes opposite changes of those found in suicide, that is, down- 
regulation of cortical 5-HT2A  receptor^.^^,^' 
Some animal studies have shown that the 5-HT2A receptor can be reg- 
ulated by steroids and by stress. Chronic social stress increases 5-HT2A 
binding in the parietal cortex of subordinate rats.RR Administration of 
ACTH for ten consecutive days decreased 5-HT2A binding in the neocor- 
tex of the rat forebrainn9 This effect is abolished by ADX and mimicked by 
corticosterone administration for ten daysBg Dexamethasone treatment 
for the same amount of time also causes a dose-dependent increase in 
5-HT2A binding in the suggesting that this effect is mediated by 
the GR. These effects of stress and steroids on cortical 5-HT2A are again 
in the direction expected if stress and HPA activation are contributing to 
the 5-HT receptor changes observed in suicide victims. Like the hip- 
pocampal5-HT1A changes, it is not clear if this is a direct effect of corti- 
costeroids on the receptors themselves or if these effects are secondary to 
steroid-induced changes in serotonin levels. Interestingly, the effect of 
corticosteroids on 5-HT2A receptor number seems to be specific for the 
cortex. Neither chronic social stress8* nor dexamethasone administration%’ 
altered 5-HT2A binding in the rat hippocampus. Given the abundance of 
both MR and GR in the hippocampus, and the lack of MR in the cortex, it 
is plausible that 5-HT receptor regulation in the cortex is mediated 
through different mechanisms than in the hippocampus. For example, 
5-HT2A may be more responsive to antecedent changes in the endoge- 
nous ligand ( ie . ,  serotonin) than to direct regulation by corticosteroids, as  
occurs with hippocampal 5-HTl A receptors. 
Some investigators have suggested that a balance between cortical 
5-HT2A and hippocampal 5-HT1A receptors is essential for an animal‘s abil- 
ity to respond to stress.” It is not clear whether the 5-HT2A and 5-HT1A 
receptor changes observed in hypercorticoid states represent an adaptive 
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response to stress or a breakdown of this adaptive mechanism. 
Nevertheless, the fact that antidepressants reverse many of the behavioral 
and neuroendocrine changes provoked by chronic stress and at the same 
time revert or oppose the 5-HT2A and 1A receptor changes points to an 
important role of these two receptors in the control of mood and perhaps in 
the pathophysiology of suicide. 
SEROTONIN TRANSPORTER AND CORTICOSTEROID 
REGULATION 
The 5-HT receptor changes discussed above describe mostly a postsy- 
naptic effect of corticosteroids on serotonergic function. However, sero- 
tonergic transmission is also controlled by presynaptic mechanisms. For 
example, antidepressants are believed to exert their therapeutic action by 
blocking the reuptake serotonin from synaptic  terminal^.^',^^ The reuptake 
of serotonin is mediated by a specific 5-HT transporter located in the 
presynaptic membrane. Changes in transporter sites and transporter 
mRNA levels have been reported to follow chronic antidepressant treat- 
ment;'~~~ indicating that regulation of this molecule is intimately linked to 
the concentration of 5-HT in the synapse. Arango and collaboratorsn have 
reported a significant decrease in serotonin transporter binding in the 
prefrontal cortex of suicide victims. This suggests that abnormalities in 
the serotonin transporter are linked to the serotonergic dysfunction pos- 
tulated to occur in suicide victims. 
In order to investigate whether corticosteroids have an effect in sero- 
tonin receptor binding and whether that effect was consistent with that 
found in suicide victims, we performed two experiments investigating the 
effect of ADX, dexamethasone administration, and chronic unpredictable 
stress on serotonin transporter sites in the hippocampus and cortex. 
In one experiment (FIG. 3), rats were either ADX (n = 12) or sham-oper- 
ated (n=11), as described above. ADX animals received 0.9% saline as 
drinking water. Five ADX animals received once daily injections of dex- 
amethasone (50 ug ip) for 1 week; the remaining ADX animals received 
daily injections of saline for the same time period. Sham ADX animals 
received daily injections of saline (n = 6) or dexamethasone (n = 5) in an 
identical fashion to ADX groups. After one week, all animals were sacri- 
ficed by decapitation, brains were removed and total serotonin trans- 
porter sites were measured in the hippocampus and cortex by receptor 
autoradiography, using 3Hpar~xetine. We found no significant differences 
between any of the groups. Therefore, neither removal of circulating 
steroids nor dexamethasone administration had an impact on serotonin 
transporter sites in the areas studied. 
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FIGURE 3. 5-HT transporter binding sites in the hippocampus. Animals were 
adrenalectomized (ADX) or sham operated for one week and received daily injec- 
tions of dexamethasone (Dex) or saline. No differences were detected in total 
3Hparoxetine binding between any of the groups. I, sham saline; a, sham Dex; 
I, ADX saline; 0 ,  ADX Dex. 
In another experiment we investigated the effect of two weeks of 
chronic unpredictable stress(ref) and antidepressant administration on 
3Hpar~xetine binding in the same brain areas (FIG. 4). Rats were divided 
into four groups (n = 6/group). One group received saline injections daily 
(controls), another group received daily intraperitoneal (ip) injections of 
imipramine (10 mg/kg), a third group underwent daily sessions of 
chronic unpredictable stress and saline injections, and a fourth group 
received both daily stress and imipramine. Animals in all treatment 
groups were sacrificed by decapitation on day 15; brains were removed 
and processed for serotonin transporter measurement as above. As in the 
ADX study, we did not find any effect of chronic stress on 5-HT trans- 
porter sites in the hippocampus or cortex. 
These studies suggest that circulating corticosteroids have very little 
effect in modulating the number of 5-HT transporter sites, at least in the 
areas studied. This speaks against the possibility that hyperactivity of the 
HPA axis is responsible for the decrease in transporter sites reported in 
suicide This of course does not rule out the possibility that 
steroids may be affecting the function of the serotonin transporter. A 
recent paper has reported that dexamethasone can increase the reuptake 
of serotonin in platelets, without affecting the number of transporter 
~ites.~'  The possibility that this may be occurring in the brain deserves fur- 
ther exploration in animal studies. 
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FIGURE 4. Two weeks of chronic unpredictable stress or daily imipramine 
administration (10 mg/kg) had no sigruficant effect in the binding of ['Hlparox- 
etine in rat hippocampus. Panel A shows the plasma corticosterone levels. Panel 
B shows the paroxetine binding (BmJ across all hippocampal subfields and the 
cortex. I, saline; a, imipramine; I, stress saline; 0 ,  stress imipramine. 
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EARLY LIFE STRESS AND HPA REGULATION 
Up to this point we have reviewed evidence showing that stress has 
important biological consequences in the brain of the adult animal. The 
impact of stress, manifested by hyperactivity of the HPA axis and result- 
ing in biochemical changes in the limbic circuitry, may provide a neurobi- 
ological underpinning to the correlation that has been described between 
life stressors, depression and suicide. Another important correlation that 
emerges in the clinical literature is between psychosocial stressors early 
in life and suicidal behavior.2’ For example, psychiatric patients with a 
history of suicide attempts have a higher incidence of parental Ioss,’~ 
maternal loss,qh and parental separation” than do nonsuicidal patients. 
Suicide attempters experience significantly more negative and less posi- 
tive parental rearing factors than n~nattempters.’~ Children and adoles- 
cents who attempt suicide have significantly more chaotic family 
situations than controls.y8 Parental loss may also be a factor in completed 
suicides.w 
It is likely that these early life events have important psychological 
consequences, manifested by an increase in suicide risk, as well as an 
increased risks for depression and substance abuse. However, in addition 
to the psychosocial consequences, animal studies suggest that early 
”stressful” events may also have important neurobiological effects. It is 
known that stress, and activation of the neuroendocrine stress system, can 
have important consequences for a developing organism. Studies in 
rodents show that the developing brain may be more sensitive to changes 
in circulating corticosteroids than the adult and therefore acti- 
vation of the HPA axis could have a more negative impact on the brain 
systems that participate in the modulation of mood, cognition, and 
behavioral control. 
Early in life, there is a delicate and critical balance of the activity of the 
HPA axis to maintain very low glucocorticoid levels. During the first two 
weeks postnatally, from day 3 to 14, the HPA stress system is character- 
ized by a ”silent period,” during which the developing infant rat is 
hyporesponsive to stress (stress hypo-responsive period or SHRP).lO’,lM 
During this time the animal maintains very low levels of circulating cor- 
ticosterone even under conditions of stimuli that normally elicit corticos- 
terone elevations in adults. In view of the catabolic influence of 
corticosteroids on growing and differentiating systems, the SHRP serves 
a highly adaptive function, allowing anabolic events to predominate dur- 
ing this period. 
Maternal behavior influences several physiological processes in the 
developing infant, including the relative stress hyporesponsiveness 
unique to the SHRP. Levine and co-workers have found that, following 24 
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hours of maternal deprivation the neonatal rat responds with significant 
increases in ACTH and corticosterone when exposed to novelty, injection 
of isotonic or hypertonic saline, and ether  vapor^.'^^^'^ These endocrine 
responses observed in the maternally deprived animals are unique and 
resemble the stress response seen in developing animals during their 
weaning period (25 days old)'O* and also the stress response of adult ani- 
mals subjected to disruption of their hippocampal-hypothalamic connec- 
tions.'* Under all of these models, the animal has elevated basal 
corticosterone levels, and these levels also remain elevated for a pro- 
longed time after the stressor. Thus, deprivation of maternal nurturing 
activities results in a hyperresponse of the HPA axis to a stressor at a time 
in the animal's life when the axis is usually quiescent. 
Vhzquez and collaborator~'~~ have shown that the HPA response to 
maternal separation is associated with a decrease of MR mRNA expres- 
sion in the CA1 region of the developing hippocampus. These animals 
also show a significant decrease in 5-HT1A mRNA in the same brain 
region (FIG. 5). It is not clear if these receptor changes in the hippocampus 
are due to a direct effect of maternal deprivation or are secondary to the 
initial increase in corticosteroid levels. However, it is apparent from this 
study that the small but significant decrease in MR mRNA levels may be 
sufficient to offset the normal age-related increase in MR mRNA levels in 
this region. Given the importance of hippocampal MR in maintaining or 
enhancing synaptic responsiveness, a decrease in MR gene expression 
may have direct repercussions in the modulation of HPA activity. It may 
also have important consequences for the activity of serotonin in the hip- 
pocampus. 
There is evidence that the disturbances in HPA activity secondary to 
maternal separation have long-lasting effects into adulthood. Adult rats 
that underwent maternal separation have higher hypothalamic CRH 
mRNA content than unhandled rats.108 In addition, maternally deprived 
rats have an increase in both basal and stress-induced ACTH levels, as 
well as an increase in CRH immunoreactivity in the median eminence.'03 
Interestingly, brief daily periods of handling (15 minutes) during the first 
two weeks of life have opposite effects in the HPA axis of adult animals."" 
Handled animals show, as adults, lower CRH mRNA levels, an increased 
number of glucocorticoid receptors in the hippocampus and hypothala- 
mus and enhanced negative feedback of the HPA axis."O These adult ani- 
mals also have significantly lower 5-HT2A binding in the frontal cortex 
compared to unhandled animals, as well as an increase in 5-HT 
turnover."' 
It is clear then from these studies that manipulations early in the life 
of the developing organism influences the activity of the HPA axis and 
alters the stress response. These alterations are long lasting and are 
accompanied by alterations in the serotonin system, which may persist 
into adulthood. 
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FIGURE 5. Twenty-four hours of maternal deprivation reduces 5-HTIA mRNA 
levels in CA1 and CA2 hippocampal subfields in 9- and 12-day old rats (A). A 
decrease in MR mRNA levels was also observed in CAI, but not in CA2 (B). 
*Significantly different from nondeprived animals, p 2 0.05. u , nondeprived; 
I, deprived. 
MONOAMINE REGULATION OF GR AND MR IN 
THE HIPPOCAMPUS 
Although it is clear that corticosteroids can regulate 5-HT receptors, it 
is also important to remember that regulation can exist in the other direc- 
tion. Acute administration of 5-HTl A and 5-HT2 agonists causes release 
of ACTH and corticosteroids, and chronic administration of 5-HT ago- 
nists and reuptake inhibitors are capable of upregulating GR and MR in 
the limbic system.”’ Monoamine tone seems to be essential for the main- 
tenance of normal GR and MR levels in the hippocampus. In order to 
study the effect of removing this monoamine tone on MR and GR recep- 
tors, we gave rats daily injections of methamphetamine (20 mg/kg, sub 
cutaneously, twice daily for 4 days) and compared them to animals that 
received saline injections. High doses of methamphetamine are neuro- 
toxic to both dopamine and serotonin neurons.”’J“ Animals were sacri- 
124 ANNALS NEW YORK ACADEMY OF SCIENCES 
ficed after two weeks, and we analyzed GR and MR levels in the hip- 
pocampus using in situ hybridization. We found that amphetamine 
administration caused a decrease in both MR and GR mRNA levels in the 
hippocampus (FIG. 6). That this effect of methamphetamine is mediated 
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i oa 
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FIGURE 6. Four consecutive days of amphetamine administration at neurotoxic 
doses results in significant decreases in GR (A) and MR (B) mRNA levels in rat 
hippocampus. *Significantly different from saline, p 2 0.05. 0 ,  saline; 
I, methamphetamine. 
L6PEZ et al.: 5-HT RECEPTOR REGULATION AND THE HPA AXIS 125 
by 5-HT has been confirmed by the fact that specific destruction of central 
serotonergic neurons using 5,7-dihydroxytryptamine also decreases lup- 
pocampal GR and MR gene expression."' These data clearly point out that 
the relationship between corticosteroids and serotonin in the hippocam- 
pus is bidirectional, complex, and tightly controlled. 
CONCLUSIONS AND FUTURE PROSPECTS 
Based on the animal studies reviewed above, we can generate a work- 
ing model of the interplay between the stress axis and the monoamines, 
and their potential interactions in suicide and depression. Although it is 
possible that some monoamine receptor changes are due to antecedent 
changes in their endogenous ligands, we propose that many of the recep- 
tor changes observed may be a result of the HPA overactivity present in 
at least some suicide victims, in particular those with a history of affective 
disorders. The rationale for this hypothesis derives from the above evi- 
dence, which can be summarized as  follows. 
(I) Suicide victims, in general, and depressed patients, in particular, 
show evidence of overactivity of the stress axis. (2 )  Chronic stress and/or 
h g h  steroid levels in rats results in an alteration of specific 5-HT recep- 
tors (e.g., increases in cortical 5-HT2A, decreases in hippocampal 5-HTl A) 
in terminal projection fields. (3)  Most human receptor binding studies 
show the same changes in the brains of suicide victims (e.g., increases in 
cortical 5-HT2A) as are found in hypercorticoid states. Our human data 
suggest a decrease in 5-HT1A mRNA levels in the hippocampi of 
depressed suicide victims (as seen with chronically stressed animals). (4) 
Chronic antidepressant administration causes opposite receptor changes 
to those seen with chronic stress (e.g., downregulation of 5-HT2A cortical 
receptors, upregulation of hippocampal 5-HTlA receptor). (5) 
Antidepressant administration reverses the overactivity of the HPA axis. 
Keeping in mind these observations, it is possible to construct a model of 
the relationships among stress hormones, monoamine receptors, and 
mood. We will illustrate these relationships using the 5-HT receptors, but 
the same model can be applied to the noradrenergic system. 
If indeed the 5-HT1A and 5-HT2A (and perhaps 5-HTlB) receptors 
have at least a partial role in controlling affective states (either directly or 
secondarily through other systems), then their modulation by corticos- 
teroids provides a potential mechanism by which these hormones may 
regulate mood. This of course does not exclude the possibility that 
steroids can be simultaneously acting through other systems, such as the 
a and p adrenoreceptors, thereby synergistically affecting mood and 
behavior. 
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If hypersecretion of endogenous corticosteroids can affect these 5-HT 
receptors, is it possible that the hypercortisolemia present in some 
depressed patients may be contributing to the affective disturbance? This 
possibility has been raised by some  investigator^"^,^^' based on the paral- 
lelisms between Cushing's disease and depression. Interestingly, patients 
with major depression who are resistant to antidepressant treatment 
experienced a dramatic improvement when they received steroid sup- 
pression agents.Il8 Additionally, patients who respond to antidepressant 
treatment, but who continue to show cortisol nonsuppression after dex- 
amethasone administration, have a much greater risk of relapsing than 
patients who show dexamethasone suppre~sion."~ Therefore, antidepres- 
sant agents, in addition to having a direct effect by correcting the central 
neurotransmitter "disturbance," may also be improving depression indi- 
rectly by decreasing cortisol hypersecretion. 
Corticosteroid modulation of 5-HT receptors has important implica- 
tions for the pathophysiology and treatment of both affective disorders 
and suicide. This may be one of the mechanisms by which stressful events 
can precipitate depressive episodes in some (genetically) vulnerable indi- 
viduals and or precipitate suicidal behavior. Another implication is that 
altered 5-HT levels or metabolism do not necessarily have to be present 
for 5-HT receptor abnormalities to occur. Based on the animal data, it is 
apparent that specific 5-HT receptors may be directly regulated in 
response to alterations of corticosteroid levels. Thus, in depressed 
patients normal levels of serotonin and its metabolites may not necessar- 
ily reflect normal central 5-HT activity. 
We know that stress affects corticosteroid release, and that this may 
be one of the mechanisms through which it affects 5-HTreceptor func- 
tion. We cannot rule out, however, that stress can also affect brain 5-HT 
receptors through noncorticosteroid-mediated pathways (even perhaps 
through noradrenergic-mediated circuits). The interplay of these factors 
may lead to the emergence, or maintenance, of affective symptoms. 
Similarly, antidepressants can counteract this phenomenon by affecting 
5-HT receptor function and by simultaneously regulating 
stress-induced corticosteroid ~ecret ion. '~ ,~~ The same interaction could of 
course be occurring with other molecules implicated in the pathophysi- 
ology of suicidal behavior, such as the a and p adrenoreceptors. Clearly, 
more animal research is needed exploring the modulation by corticos- 
teroids of other monoaminergic receptors that postmortem studies have 
linked to the neurobiology of suicide.s3,120 
Inasmuch as  most antidepressants are known to reverse many of these 
receptor changes in rodents, it will be interesting to compare these mole- 
cules in suicide victims with and without a history of chronic antidepres- 
sant intake. We may expect that some of these predicted biochemical 
changes may be absent in suicide victims with a history of psychotropic 
use. Alternatively, it is possible that, in some subjects, antidepressant 
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administration was unable to reverse some of these biochemical changes. 
This inability to correct these abnormalities may be associated with the 
therapeutic failure of antidepressant treatment in these individuals who 
have committed suicide. 
An important therapeutic implication of this model is the prediction 
that agents that can reduce the stress response, and/or decrease HPA acti- 
vation, will be useful in the pharmacological treatment of anxiety, depres- 
sion, and perhaps suicidal behavior. In this respect, the recently 
developed CRH receptor antagonists may provide us with a new thera- 
peutic armamentarium to treat these patients.’21,122 These compounds 
could be used in conjuction with antidepressants, as adjuvants or aug- 
menting agents, and may decrease treatment resistance. This agents may 
also be useful in monotherapy, because preventing hypercortisolemia 
may be translated into an improvement of monoaminergic receptor func- 
tion. The use of modern biochemical and molecular neuroanatomical 
techniques in the postmortem human brain should allow us to test these 
hypotheses, first in animal models and then directly in psychiatric illness. 
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